Matilde Arévalo-Ruiz

Title: Matilde Arévalo-Ruiz: Innovator in Modified IL-2 Polypeptides

Introduction

Matilde Arévalo-Ruiz is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of modified IL-2 polypeptides. Her work focuses on innovative treatments for diseases, including cancer.

Latest Patents

Matilde holds a patent for "Modified IL-2 polypeptides and uses thereof." This patent encompasses modified IL-2 polypeptides, compositions that include these polypeptides, and methods for their production and application. The invention highlights the potential of these modified polypeptides in treating cancer by exhibiting preferential binding characteristics to the IL-2 receptor βγ complex over the IL-2 receptor αβγ complex. The molecular weight distribution of the modified IL-2 polypeptides is noted to be monodispersed, which is crucial for their effectiveness.

Career Highlights

Matilde is associated with Bright Peak Therapeutics AG, where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key figure in the biotechnology sector, contributing to the understanding and treatment of complex diseases.

Collaborations

Matilde has collaborated with notable professionals in her field, including Vijaya Raghavan Pattabiraman and Roberto Iacone. These collaborations have further enhanced her research and the impact of her inventions.

Conclusion

Matilde Arévalo-Ruiz is a trailblazer in the development of modified IL-2 polypeptides, with a focus on innovative cancer treatments. Her contributions to biotechnology are paving the way for new therapeutic approaches that could significantly improve patient outcomes.